A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases

Clinical trial NCT02077374 · COMPLETED

Trial details

NCT number: NCT02077374
Sponsor: Conatus Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis Non-alcoholic Fatty Liver Disease

Start date: 2014-03-01
Primary completion: 2015-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.